Today ARGS ranks # as HOLD CANDIDATE.
Today ARGS ranks # as HOLD CANDIDATE.

ARGS stock Argos Therapeutics

ARGS stock
Argos Therapeutics

February 21, 2019
Change 38.67%
Chart period: 2018-11-23 - 2019-02-21
VOLUME
Sell
TREND
Sell

MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Sell

Will ARGS stock price go up or down on Fri, 22 Feb 2019?

Argos Therapeutics Forecast and Stock Analysis

Technical ARGS stock analysis for February 21, 2019.

Hold candidate since 2019-02-21
Shorts 0.94% ( 2018-03-29 )
Cash n/a
Loans n/a
Beta 1.66
ROA -61.64

Argos Therapeutics gained 38.67% in the last trading day, rising from $0.05 to $0.07 The price has fallen in 4 of the last 10 days . Volume fell in the last day by -5 097 shares, and in total, 4 902 shares bought and sold for approximately $348.04. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Close price at the end of the last trading day (Thursday, 21st Feb 2019) of the ARGS stock was $0.07. This is 38.67% more than the trading day before Wednesday, 20th Feb 2019.

During day the stock fluctuated 38.67% from a day low at $0.05 to a day high of $0.07.

30 day high of the ARGS stock price was $0.10 and low was $0.04.
90 day high was $0.14 and low was $0.02.
52 week high for the Argos Therapeutics - $1.59 and low - $0.02.

Trend

Argos Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.06% during the next 3 months and, with 90% probability hold a price between $0.01 and $0.09 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

Argos Therapeutics holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $0.07 and $0.07. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday February 20, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 44 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Argos Therapeutics finds support from accumulated volume at $0.07.

Support: $0.07 Price: $0.07 Resistance: $0.07

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.02 between high and low, or 38.67%. For the last week the stock has had a daily average volatility of 27.46%.

Our recommended stoploss: $0.07 (-5.24%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation: Hold/Accumulate

Argos Therapeutics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Hold/Accumulate.

Today ARGS ranks # as HOLD CANDIDATE.
Today ARGS ranks # as HOLD CANDIDATE.